Data Sheet 1_Preventive hyperbaric oxygen therapy improves acute graft-versus-host disease by activating the Nrf2/HO-1 pathway.pdf

Data Sheet 1_Preventive hyperbaric oxygen therapy improves acute graft-versus-host disease by activating the Nrf2/HO-1 pathway.pdf

Background<p>Hyperbaric oxygen therapy (HBOT) has been confirmed as an effective and economical therapeutic modality for treating hemorrhagic cystitis (HC), whether induced by infection or acute graft-versus-host disease (aGVHD), in transplant recipients. However, its potential benefits in tre...

Full description

Saved in:
Bibliographic Details
Main Author: Chao Xue (503328) (author)
Other Authors: Hao Chen (5190) (author), Yiou Zhao (19748461) (author), Dai Yuan (11578766) (author), Xiaosheng Fang (1422040) (author), Mei Ding (243858) (author), Huiting Qu (19748464) (author), Xin Wang (91924) (author), Xueling Ge (154276) (author), Kang Lu (3449885) (author), Yujie Jiang (2991267) (author)
Published: 2025
Subjects:
Genetic Immunology
allogeneic hematopoietic stem cell transplantation
acute graft-versus host disease
hyperbaric oxygen therapy
erythroid-derived 2-related factor 2 (Nrf2)
reactive oxygen species
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items